Audience: Who have you identified as your customer/recipient groups and do these groups value your solution for different reasons? How do you engage different customer/recipient groups to deliver your solution?
Obatech contributes to the patient care ecosystem. We improve frontline worker performance for pharmacy chains and hospitals, driving up recurring and topline revenue by building patient loyalty. We give local training companies and schools alternative outlets for their curriculum. We map the patient journey, improving healthcare data for policymakers. All of these collectively improve patient outcomes.
Scaling the solution: How would the prize money and publicity help you to achieve your objectives over the next two years?
We built our solution with the support of a local Indonesian pharmacy chain, which is now demanding exclusive access to the product. Because we can't afford to deploy it independently (need to buy tablets), we're reliant on a first customer. This money could give us the metrics and market power to take time to negotiate with several customers at once, avoid exclusivity, and build a platform, which would ultimately result in an improved product for pharmacy chains and patients. We've tried raising traditional investment, but unfortunately, investors need a non-exclusive contract to provide us with funding.
Experience: Please provide examples of any previous entrepreneurial initiatives you have pioneered
Co-founder, Surge- the Social Innovation Research Group (www.sirgtaiwan.wordpress.com). With University of Toronto funding, co-founded Surge, a social enterprise mapping the Taiwanese social innovation landscape. We sold innovation-based case studies and internship opportunities to the Munk School at the University of Toronto, and is still in operation today.
Are you are eligible to attend the Accelerator event in Cambridge and subsequent events in London, UK in January, 2015?